| Switching from efavirenz to rilpivirine improves sleep quality and self-perceived cognition but has no impact on neurocognitive performances G Lapadula, DP Bernasconi, F Bai, E Focà, A Di Biagio, S Bonora, ... Aids 34 (1), 53-61, 2020 | | 2020 |
| Doravirine versus ritonavir-boosted darunavir in antiretroviral-naive adults with HIV-1 (DRIVE-FORWARD): 96-week results of a randomised, double-blind, non-inferiority, phase 3 … JM Molina, K Squires, PE Sax, P Cahn, J Lombaard, E DeJesus, MT Lai, ... The lancet HIV, 2019 | 53 | 2019 |
| Towards Rapid Sepsis Diagnosis and Patients Stratification: What’s New From Microbiology and Omics Science D Mangioni, AM Peri, GM Rossolini, B Viaggi, CF Perno, A Gori, ... The Journal of infectious diseases, 2019 | | 2019 |
| Predictors of weight gain in patients treated with dolutegravir L Taramasso, P Bonfanti, E Ricci, N Squillace, B Menzaghi, G Madeddu, ... HIV MEDICINE 20, 274-275, 2019 | | 2019 |
| miRNA expression profiling in subcutaneous adipose tissue of monozygotic twins discordant for HIV infection: validation of differentially expressed miRNA and bioinformatic analysis N Squillace, E Bresciani, V Orsini, L Rizzi, R Meanti, A Soria, G Lapadula, ... HIV MEDICINE 20, 181-182, 2019 | | 2019 |
| Determinants of switching to TAF-based cART or dual combinations (DC) from TDF-based regimens in a cohort of HIV-infected individuals with controlled viral load≤ 50 copies/mL A Vergori, R Gagliardini, N Gianotti, A Gori, M Lichtner, A Saracino, ... HIV MEDICINE 20, 84-85, 2019 | | 2019 |
| Primary Whipple disease of the Central Nervous System presenting with rhombencephalitis C Balducci, S Foresti, A Ciervo, F Mancini, G Nastasi, L Marzorati, A Gori, ... International Journal of Infectious Diseases 88, 149-151, 2019 | 1 | 2019 |
| Guidelines for the use of flow cytometry and cell sorting in immunological studies A Cossarizza, HD Chang, A Radbruch, A Acs, D Adam, S Adam‐Klages, ... European journal of immunology 49 (10), 1457-1973, 2019 | 8 | 2019 |
| Phylogenies in ART: HIV reservoirs, HIV latency and drug resistance A Bandera, A Gori, M Clerici, M Sironi Current opinion in pharmacology 48, 24-32, 2019 | 2 | 2019 |
| Incidence and risk factors for liver enzyme elevation among naive HIV-1-infected patients receiving ART in the ICONA cohort L Taramasso, P Lorenzini, A Di Biagio, M Lichtner, G Marchetti, R Rossotti, ... Journal of Antimicrobial Chemotherapy 74 (11), 3295-3304, 2019 | | 2019 |
| Randomized study evaluating the efficacy and safety of switching from an an abacavir/lamivudine-based regimen to an elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide … G Rizzardini, A Gori, C Miralles, J Olalla, JM Molina, F Raffi, P Kumar, ... Aids 33 (10), 1583-1593, 2019 | | 2019 |
| Recurrent posterior reversible encephalopathy syndrome in an HIV-HCV coinfected liver transplant recipient A Cappelletti, AM Peri, L Bisi, F Sabbatini, M Rossi, GM Migliorino, ... Aids 33 (10), 1679-1681, 2019 | 1 | 2019 |
| Adjuvant treatment of severe varicella pneumonia with intravenous varicella zoster virus-specific immunoglobulins D Mangioni, G Grasselli, C Abbruzzese, A Muscatello, A Gori, A Bandera International Journal of Infectious Diseases 85, 70-73, 2019 | 1 | 2019 |
| Hepatitis C virus–related factors associated WITH cognitive performance in HIV-HCV-coinfected patients M Fabbiani, N Ciccarelli, V Castelli, A Soria, A Borghetti, E Colella, ... Journal of neurovirology, 1-8, 2019 | 1 | 2019 |
| Nonalcoholic fatty liver disease and steatohepatitis in people living with HIV N Squillace, A Soria, G Bozzi, A Gori, A Bandera Expert review of gastroenterology & hepatology 13 (7), 643-650, 2019 | | 2019 |
| Impact of diabetes on the risk of serious liver events and liver-related deaths in people living with HIV and hepatitis C co-infection: data from the ICONA Foundation Cohort Study S Leone, P Lorenzini, A Cozzi-Lepri, G Orofino, D Bernacchia, ... European Journal of Clinical Microbiology & Infectious Diseases, 1-9, 2019 | 1 | 2019 |
| Use of colistin in adult patients: a cross-sectional study DR Giacobbe, C Saffioti, AR Losito, M Rinaldi, C Aurilio, C Bolla, S Boni, ... Journal of global antimicrobial resistance, 2019 | 2 | 2019 |
| Durability of different initial regimens in HIV-infected patients starting antiretroviral therapy with CD4+ counts< 200 cells/mm3 and HIV-RNA> 5 log10 copies/mL N Gianotti, P Lorenzini, A Cozzi-Lepri, A De Luca, G Madeddu, ... Journal of Antimicrobial Chemotherapy, 2019 | 1 | 2019 |
| Randomized study evaluating the efficacy and safety of switching from an ABC/3TC-based regimen to an E/C/F/TAF single-tablet regimen G Rizzardini, A Gori, C Miralles, J Olalla, JM Molina, F Raffi, P Kumar, ... AIDS, 2019 | | 2019 |
| A RETRO‐PROSPECTIVE STUDY IN HIV+ PATIENTS AFFECTED BY LYMPHOMA: THE MUSTHAL MULTICENTER EXPERIENCE IN NORTHERN ITALY G Rindone, A Bandera, FA Brioschi, D Dalu, F Pagni, P Vitiello, M Mena, ... Hematological Oncology 37 (S2), 530-532, 2019 | | 2019 |
Mario (mago) ClericiProfessor of Immunology and Dept Head, Universita degli Studi di Milano e Fondazione Don C GnocchiVerified email at unimi.it
